An Study of Efficacy and Safety of Clevudine

NCT01192854 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

288

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Clevudine
DRUG: Adefovir

Sponsor

Eisai Co., Ltd.